Concepedia

Francis Heitz

FH

Statistics

Publications

8

Citations

1K

H-Index

8

Active since

1987

Affiliations

Novartis (Switzerland)(Current)

Francis Heitz is an author at Novartis (Switzerland) specializing in pharmacology, drug metabolism, and medicine.

Publications per year

1987–2010

8

Publications

8

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

Mona Sedeek, Gláucia E. Callera, Augusto C. Montezano et al. · American Journal of Physiology-Renal Physiology · 2010 · 391 citations

, , +17

The 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin: Effect on Human Cytochrome P-450 and Implications for Metabolic Drug Interactions

Volker Fischer, Laurie Johanson, Francis Heitz et al. · Drug Metabolism and Disposition · 1999 · 148 citations

, , +17

Multiple Cytochrome P-450s Involved in the Metabolism of Terbinafine Suggest a Limited Potential for Drug-Drug Interactions

Alison E.M. Vickers, John Sinclair, Markus Zollinger et al. · Drug Metabolism and Disposition · 1999 · 123 citations

, , +17

The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.

Volker Fischer, Alicia Rodríguez‐Gascón, Francis Heitz et al. · PubMed · 1998 · 104 citations

, , +17

The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.

Volker Fischer, Alison E.M. Vickers, Francis Heitz et al. · Drug Metabolism and Disposition · 1994 · 95 citations

, , +16

1–5 of 8